Assessment of hepatic prostaglandin E2 level in carbamazepine induced liver injury
, , , , y
18 feb 2022
Acerca de este artículo
Publicado en línea: 18 feb 2022
Páginas: 22 - 30
DOI: https://doi.org/10.2478/enr-2022-0003
Palabras clave
© 2022 Ken-ichi Oba et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Oba, Ken-ichi
Department of Pharmacy, Faculty of Pharmacy, Kindai UniversityOsaka, Japan
Shimada, Hiroaki
Department of Pharmacy, Faculty of Pharmacy, Kindai UniversityOsaka, Japan
Hashimoto, Ryota
Department of Pharmacy, Faculty of Pharmacy, Kindai UniversityOsaka, Japan
Kawase, Atsushi
Department of Pharmacy, Faculty of Pharmacy, Kindai UniversityOsaka, Japan
Nakanishi, Takeo
Department of Pharmacy, Faculty of Pharmacy, Takasaki University of Health and WelfareTakasaki, Japan
Iwaki, Masahiro
Department of Pharmacy, Faculty of Pharmacy, Kindai UniversityOsaka, Japan
Pharmaceutical Research and Technology Institute, Kindai UniversityOsaka, Japan
Antiaging Center, Kindai UniversityOsaka, Japan